Corporate News     15-Jul-19
KDDL infuses Rs 10.99 cr in Ethos
Increases stake in Ethos to 73.56%
KDDL announced that its material subsidiary, Ethos, has raised funds amounting to Rs 10.99 crore by way of preferential allotment of 376,712 fully paid equity shares of Rs. 10 each at a premium of Rs. 282 per share to KDDL, holding company.

Post the above allotment, consolidated shareholding of KDDL (directly and indirectly through its subsidiary, Mahen Distribution) in Ethos will increase from 72.99% to 73.56% on a fully diluted basis.

Previous News
  Board of KDDL approves buyback of up to Rs 21 cr
 ( Corporate News - 19-Jan-23   10:35 )
  KDDL gains on incorporating new subsidiary in Chandigarh
 ( Hot Pursuit - 21-Mar-25   10:30 )
  KDDL rallies as board to mull share buyback on Jul 9
 ( Hot Pursuit - 05-Jul-24   10:43 )
  Board of KDDL recommends Interim Dividend
 ( Corporate News - 03-Mar-20   10:02 )
  KDDL board approves share buyback
 ( Hot Pursuit - 19-Jan-23   09:42 )
  KDDL consolidated net profit rises 1703.55% in the September 2023 quarter
 ( Results - Announcements 15-Nov-23   16:16 )
  KDDL to hold EGM
 ( Corporate News - 08-Oct-16   12:47 )
  KDDL acquires balance stake in Swiss watch component maker - Pylania
 ( Corporate News - 19-Nov-22   12:49 )
  KDDL announces board meeting date
 ( Corporate News - 06-Aug-19   14:04 )
  KDDL to conduct board meeting
 ( Corporate News - 15-Jan-24   12:24 )
  KDDL to convene board meeting
 ( Corporate News - 06-Feb-23   14:52 )
Other Stories
  Board of HCL Technologies recommends Interim Dividend
  14-Jul-25   17:52
  Objectone Information Systems to conduct board meeting
  14-Jul-25   17:50
  JTEKT India AGM scheduled
  14-Jul-25   17:50
  Setco Automotive to discuss results
  14-Jul-25   17:50
  Saurashtra Cement to hold board meeting
  14-Jul-25   17:49
  John Cockerill India to table results
  14-Jul-25   17:49
  ATV Projects India to conduct board meeting
  14-Jul-25   17:49
  Shilchar Technologies schedules AGM
  14-Jul-25   17:49
  Sun Pharma settles litigation related to LEQSELVI™ with Incyte
  14-Jul-25   16:53
  Sun Pharmaceutical Industries launches LEQSELVI™ (deuruxolitinib) 8 mg tablets in United States
  14-Jul-25   16:48
Back Top